CROSS Research
Arlesheim, Switzerland Specialty Founded 2002 51-200 employees
Swiss independent Phase I and early-phase clinical CRO in Basel with a dedicated 24-bed clinical pharmacology unit, specializing in first-in-human studies for oncology, cardiovascular, and CNS compounds.
Services
PRECLINICAL
ANALYTICAL
REGULATORY
Therapeutic Areas
Certifications
Regulatory Experience
FDAEMA